Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 4 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment.
Front Immunol. 2022 Oct 13;13:980698. doi: 10.3389/fimmu.2022.980698. eCollection 2022.
Front Immunol. 2022.
PMID: 36311723
Free PMC article.
GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine.
Čiučiulkaitė I, Möhlendick B, Thümmler L, Fisenkci N, Elsner C, Dittmer U, Siffert W, Lindemann M.
Čiučiulkaitė I, et al. Among authors: fisenkci n.
Front Genet. 2022 Aug 29;13:932043. doi: 10.3389/fgene.2022.932043. eCollection 2022.
Front Genet. 2022.
PMID: 36105097
Free PMC article.
Item in Clipboard
Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients.
Thümmler L, Gäckler A, Bormann M, Ciesek S, Widera M, Rohn H, Fisenkci N, Otte M, Alt M, Dittmer U, Horn PA, Witzke O, Krawczyk A, Lindemann M.
Thümmler L, et al. Among authors: fisenkci n.
Vaccines (Basel). 2022 Aug 18;10(8):1348. doi: 10.3390/vaccines10081348.
Vaccines (Basel). 2022.
PMID: 36016235
Free PMC article.
Item in Clipboard
Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients.
Thümmler L, Koldehoff M, Fisenkci N, Brochhagen L, Horn PA, Krawczyk A, Lindemann M.
Thümmler L, et al. Among authors: fisenkci n.
Vaccines (Basel). 2022 Jun 18;10(6):972. doi: 10.3390/vaccines10060972.
Vaccines (Basel). 2022.
PMID: 35746580
Free PMC article.
Item in Clipboard
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis.
Pompsch M, Fisenkci N, Horn PA, Kraemer M, Lindemann M.
Pompsch M, et al. Among authors: fisenkci n.
Neurol Res Pract. 2021 Nov 22;3(1):60. doi: 10.1186/s42466-021-00158-5.
Neurol Res Pract. 2021.
PMID: 34802469
Free PMC article.
Item in Clipboard
Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients.
Lindemann M, Klisanin V, Thümmler L, Fisenkci N, Tsachakis-Mück N, Ditschkowski M, Schwarzkopf S, Klump H, Reinhardt HC, Horn PA, Koldehoff M.
Lindemann M, et al. Among authors: fisenkci n.
Vaccines (Basel). 2021 Sep 25;9(10):1075. doi: 10.3390/vaccines9101075.
Vaccines (Basel). 2021.
PMID: 34696183
Free PMC article.
Item in Clipboard
Cite
Cite